Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pregabalin + venlafaxine
- Development stage
- Unknown
- Lead developer
- Beijing Tiantan Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Pregabalin + venlafaxine is a combination therapy being investigated by Beijing Tiantan Hospital for the treatment of moderate to severe fibromyalgia. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that modulates pain pathways by increasing the availability of serotonin and norepinephrine in the central nervous system. Pregabalin is a gabapentinoid that binds to the alpha-2-delta subunit of voltage-gated calcium channels, thereby reducing the release of excitatory neurotransmitters. The combination aims to provide superior pain relief compared to pregabalin monotherapy by targeting multiple pathways involved in central sensitization and neurotransmitter imbalance associated with fibromyalgia.
- Brand names
- EffexorLyrica
- Other names
- venlafaxine-Beijing Tiantan Hospital-fibromyalgia
02
Targets
NET (Norepinephrine Transporter)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on pregabalin + venlafaxine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pregabalin + venlafaxine.